Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
- Conditions
- IgG4-related Disease
- Interventions
- Biological: extra blood draw samples
- Registration Number
- NCT02899039
- Lead Sponsor
- Assistance Publique Hopitaux De Marseille
- Brief Summary
IgG4-related disease is a rare and very recently identified pathology, whose frequency is certainly underestimated.
The clinical presentation varies among affected organs, and most often, patients have at least three organ damage.
These organs exhibit tissue infiltration mononuclear polymorphic cells with often severe fibrosis progression resulting in a loss of function.
The biomarker, though not specific, is a polyclonal elevated serum IgG4, and histological marker, currently held by several teams, is the presence within the inflammatory infiltrate, of a predominance of IgG4-expressing plasma-cells with a relative plasma-cells IgG4 + / IgG +\> 50% on tissue immunostaining.
The investigators project provides a global assessment of T lymphocyte abnormalities and specifically the TFH (Follicular Helper) during this IgG4-related disease compared to so-called groups "control" subjects suffering from Sjogren syndrome or healthy subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- IgG4-related disease patients or
- Sjogren syndrome patients or
- Healthy subjects
- Presence of autoimmune or inflammatory associated disease
- Age less than 18 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Healthy controls extra blood draw samples Healthy subjects IgG4-related disease extra blood draw samples Subjects suffering from IgG4-related disease Sjögren syndrome extra blood draw samples Subjects suffering from Sjôgren syndrome
- Primary Outcome Measures
Name Time Method Proportion of Follicular Helper T cells (CD4 + CXCR5 + ICOShigh) in the blood 36 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
APHM
🇫🇷Marseille, France